Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat COVID-19

NEXT STORY
I-Mab Announces Upcoming Participation at March Conferences
PREV STORY
Avadim Health Announces Over-the-Counter Launch of Theraworx® Protect U-Pak
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research

Press Release 18 June 2018 Immunicum AB (publ) Announces Publication of Scientific Review of ...

author_avatar
NASDAQ Market News

DGAP-News: RedHill Biopharma Ltd.: RedHill Biopharma Provides 2016 R&D Update

DGAP-News: RedHill Biopharma Ltd. / Key word(s): Miscellaneous RedHill Biopharma Ltd.: RedHill Biopharma Provides ...

author_avatar
NASDAQ Market News

Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that ...

author_avatar
NASDAQ Market News